NASDAQ
Actuate Therapeutics Inc (ACTU) has a free cash flow growth of -34.30% as of Friday, May 29, 2026. This represents a 31517.64% decrease compared to its 12-month average of -0.11%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.